Results 121 to 130 of about 1,236 (184)

Psychedelics for major depression-From controlled research settings into broader clinical use. [PDF]

Cell Rep Med
Avram M, Borgwardt S.
europepmc   +1 more source

Predicting drug-drug interactions between ayahuasca alkaloids and SSRIs using physiologically based pharmacokinetic modeling. [PDF]

Front Mol Biosci
Ribeiro GSG, Paranhos BAPB, Dörr F, Yonamine M, Villanova B, Guerra LTL, Raminelli AO, Reis JAS, de Paula CC, Zacharias ABV, Cecílio Hallak JE, Dos Santos RG, Martins FS, Marcourakis T.   +13 more
europepmc   +1 more source

The Role of Ayahuasca in Colorectal Adenocarcinoma Cell Survival, Proliferation and Oxidative Stress. [PDF]

Pharmaceuticals (Basel)
Gonçalves J, Feijó M, Socorro S, Luís Â, Gallardo E, Duarte AP.   +5 more
europepmc   +1 more source

Cardiac effects of two hallucinogenic natural products, N,N-dimethyl-tryptamine and 5-methoxy-N,N-dimethyl-tryptamine. [PDF]

Sci Rep
Neumann J, Dietrich T, Azatsian K, Hofmann B, Gergs U.   +4 more
europepmc   +1 more source

Metabolic profiling reveals first evidence of fumigating drug plant Peganum harmala in Iron Age Arabia. [PDF]

Commun Biol
Huber B, Luciani M, Abualhassan AM, Giddings Vassão D, Fernandes R, Devièse T.   +5 more
europepmc   +1 more source

Psychedelics as a Therapeutic Opportunity or Threat: A Narrative Review. [PDF]

Cureus
Liszka P, Ogórek A, Olejnik-Chlewicka KM, Puchalski K, Zasiadła M, Patrzykąt KM, Perediatkiewicz J, Urbański W, Łuczak PM, Brodowski J.   +9 more
europepmc   +1 more source

Untargeted metabolomics reveals quinic acid as the kiwifruit component that affects brain activity in mice. [PDF]

PLoS One
Marzo CM, Bianconi M, Commisso M, Gambini S, Chiamulera C, Avesani L, Negri S, Guzzo F.   +7 more
europepmc   +1 more source